120 related articles for article (PubMed ID: 20708466)
1. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
Kwakkel-van Erp JM; Haeck IM; Paantjens AW; van de Graaf EA; van Ginkel WG; Knol MJ; de Bruin-Weller MS; Lammers JW; Knol EF; Bruijnzeel-Koomen C; Otten HG
J Am Acad Dermatol; 2010 Sep; 63(3):e70-2. PubMed ID: 20708466
[No Abstract] [Full Text] [Related]
2. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
Haeck IM; Knol MJ; Ten Berge O; van Velsen SG; de Bruin-Weller MS; Bruijnzeel-Koomen CA
J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
[TBL] [Abstract][Full Text] [Related]
3. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
4. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
[TBL] [Abstract][Full Text] [Related]
5. [TARC (thymus and activation regulated chemokine)].
Nakamura K
Nihon Rinsho; 2010 Jun; 68 Suppl 6():41-5. PubMed ID: 20941997
[No Abstract] [Full Text] [Related]
6. Different effect of oral cyclosporine therapy and oral antihistamine therapy on serum high-sensitivity C-reactive protein level and thymus and activation-regulated chemokine level in atopic dermatitis in older children and adulthood.
Ohtsuka T
Int J Dermatol; 2015 Jun; 54(6):648-55. PubMed ID: 25312097
[TBL] [Abstract][Full Text] [Related]
7. CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity.
Oflazoglu E; Simpson EL; Takiguchi R; Grewal IS; Hanifin JM; Gerber HP
Eur J Dermatol; 2008; 18(1):41-9. PubMed ID: 18086588
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.
Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML
Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin maintenance therapy for severe atopic dermatitis.
Korstanje MJ; van de Staak WJ
Acta Derm Venereol; 1991; 71(4):356-7. PubMed ID: 1681659
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
[TBL] [Abstract][Full Text] [Related]
12. [Biomarker of atopic dermatits -focusing on serum TARC/CCL17 level as severity marker-].
Saeki H
Arerugi; 2013 Feb; 62(2):131-7. PubMed ID: 23531648
[No Abstract] [Full Text] [Related]
13. Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized, placebo-controlled, double-blind, parallel clinical trial.
Jin SY; Lim WS; Sung NH; Cheong KA; Lee AY
Dermatol Ther; 2015; 28(1):44-51. PubMed ID: 25113885
[TBL] [Abstract][Full Text] [Related]
14. Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis.
Kyoya M; Kawakami T; Soma Y
J Dermatol Sci; 2014 Sep; 75(3):204-7. PubMed ID: 24984931
[No Abstract] [Full Text] [Related]
15. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS).
Furusyo N; Takeoka H; Toyoda K; Murata M; Maeda S; Ohnishi H; Fukiwake N; Uchi H; Furue M; Hayashi J
Eur J Dermatol; 2007; 17(5):397-404. PubMed ID: 17673383
[TBL] [Abstract][Full Text] [Related]
16. Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis.
Kimura T; Sugaya M; Suga H; Morimura S; Miyamoto A; Kai H; Kagami S; Yanaba K; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2014 May; 94(3):331-2. PubMed ID: 24104601
[No Abstract] [Full Text] [Related]
17. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
Heshmat NM; El-Hadidi ES
Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
[TBL] [Abstract][Full Text] [Related]
18. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
19. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
20. [Objective measurements of disease severity and diagnostic confirmation in atopic dermatitis and urticaria].
Mihara S
Arerugi; 2012 Jan; 61(1):10-7. PubMed ID: 22398423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
